MedPath

efficacy of fentanyl and neostigmine combination in spinal anaesthesia

Not Applicable
Registration Number
CTRI/2022/06/043043
Lead Sponsor
hitender kumar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

asa 1 and 2, surferies below the umbilicus under spinal anaesthesia

Exclusion Criteria

platelet count less than 100000/cu mm

asa class 3 and 4

sensitivity to local anaesthestics

history of heart failure or kidney or liver disease

history of neurological disorder

failed spinal anaesthesia

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
onset of sensory, motor blockade and mximum dermatome achieved, time for 2 segment regression of sensory blockadeTimepoint: 6 months
Secondary Outcome Measures
NameTimeMethod
haemodynamic parameter- HR, SBP, DBP, MBP, SPO2..incidence of sedation/nausea vomiting upto 2 hours postoperativelyTimepoint: 2 hours postoperatively
© Copyright 2025. All Rights Reserved by MedPath